| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12519-015-0062-Y |
| P698 | PubMed publication ID | 26684309 |
| P2093 | author name string | Hae Il Cheong | |
| Young Seo Park | |||
| Hyun Jin Choi | |||
| Eun Mi Yang | |||
| Hee Yeon Cho | |||
| Il-Soo Ha | |||
| Joo Hoon Lee | |||
| Sang Taek Lee | |||
| Hee Gyung Kang | |||
| P2860 | cites work | Corticosteroid therapy for nephrotic syndrome in children | Q24243163 |
| Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients | Q24245456 | ||
| New equations to estimate GFR in children with CKD | Q24642417 | ||
| Posttransplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). | Q30307986 | ||
| Immunosuppressive strategies in transplantation | Q33591791 | ||
| Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome | Q34281816 | ||
| Immunosuppressive treatment for nephrotic idiopathic membranous nephropathy: a meta-analysis based on Chinese adults | Q34408113 | ||
| Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children | Q34659232 | ||
| Tacrolimus and posttransplant diabetes mellitus in renal transplantation | Q36154176 | ||
| Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients | Q37334715 | ||
| Second-line immunosuppressive treatment of childhood nephrotic syndrome: a single-center experience | Q38191615 | ||
| A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation | Q38494134 | ||
| Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome | Q42689190 | ||
| Second-line options for refractory steroid-sensitive and -resistant nephrotic syndrome | Q42723614 | ||
| Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome | Q43461510 | ||
| A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children | Q43588188 | ||
| Primary focal segmental glomerulosclerosis in children: prognostic factors | Q43717863 | ||
| Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. | Q43830007 | ||
| Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. | Q43961758 | ||
| Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial | Q44069303 | ||
| Effective tacrolimus treatment in a child suffering from severe nephrotic syndrome | Q44398334 | ||
| Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome | Q44752973 | ||
| Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial | Q46096920 | ||
| Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus | Q46823230 | ||
| Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children | Q46881412 | ||
| One-year observation of kidney allograft recipients converted from cyclosporine microemulsion to tacrolimus. | Q46966000 | ||
| Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation. | Q46966024 | ||
| Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome | Q47417726 | ||
| Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. | Q53360030 | ||
| A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults. | Q53574932 | ||
| FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood. | Q54327935 | ||
| Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus | Q79422909 | ||
| Is tacrolimus for childhood steroid-dependent nephrotic syndrome better than ciclosporin A? | Q83347988 | ||
| Transient insulin-dependent diabetes mellitus in children with steroid-dependent idiopathic nephrotic syndrome during tacrolimus treatment | Q83989253 | ||
| Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome | Q84415164 | ||
| Comparison of adverse drug reaction profiles of two tacrolimus formulations in rats | Q85039691 | ||
| P433 | issue | 1 | |
| P921 | main subject | nephrotic syndrome | Q504790 |
| P304 | page(s) | 60-65 | |
| P577 | publication date | 2015-12-18 | |
| P1433 | published in | World Journal of Pediatrics | Q15763275 |
| P1476 | title | Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula. | |
| P478 | volume | 12 |
| Q53702610 | Calcineurin inhibitors and nephrotoxicity in children. |
| Q89137674 | Efficacy of Rituximab vs Tacrolimus in Pediatric Corticosteroid-Dependent Nephrotic Syndrome: A Randomized Clinical Trial |
| Q52594698 | Population Pharmacokinetics of Tacrolimus in Children with Nephrotic Syndrome. |
| Q64111320 | Population pharmacokinetics of tacrolimus in pediatric refractory nephrotic syndrome and a summary of other pediatric disease models |
Search more.